MK801 attenuates behavioural adaptation to chronic nicotine administration in rats
- PMID: 1628139
- PMCID: PMC1908456
- DOI: 10.1111/j.1476-5381.1992.tb09010.x
MK801 attenuates behavioural adaptation to chronic nicotine administration in rats
Abstract
The effect of administering MK801 (0.3 mg kg-1) during chronic nicotine (0.4 mg kg-1) treatment was studied on locomotor activity in rats. Sensitization of the locomotor activity response to nicotine was seen with chronic nicotine treatment. This sensitization was attenuated in rats that had received MK801 30 min before the daily nicotine injections during chronic treatment. These results suggest that the NMDA receptor may be involved in the adaptive processes seen with chronic nicotine administration.
Similar articles
-
Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist.Psychopharmacology (Berl). 1997 Nov;134(2):121-30. doi: 10.1007/s002130050433. Psychopharmacology (Berl). 1997. PMID: 9399375
-
Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats.Psychopharmacology (Berl). 2002 Jun;161(4):370-8. doi: 10.1007/s00213-002-1015-4. Epub 2002 Apr 20. Psychopharmacology (Berl). 2002. PMID: 12073164
-
The NMDA antagonist dizocilpine (M K801) attenuates tolerance to nicotine in rats.J Psychopharmacol. 1996 Jan;10(3):214-8. doi: 10.1177/026988119601000306. J Psychopharmacol. 1996. PMID: 22302947
-
Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801.J Pharm Pharmacol. 2004 Aug;56(8):1021-8. doi: 10.1211/0022357043888. J Pharm Pharmacol. 2004. PMID: 15285847
-
Nicotine psychopharmacology: addiction, cognition and neuroadaptation.Med Res Rev. 1995 Jan;15(1):47-72. doi: 10.1002/med.2610150105. Med Res Rev. 1995. PMID: 7898169 Review. No abstract available.
Cited by
-
The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access.Psychopharmacology (Berl). 2007 Sep;194(1):53-61. doi: 10.1007/s00213-007-0822-z. Epub 2007 May 27. Psychopharmacology (Berl). 2007. PMID: 17530475
-
The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.Yonsei Med J. 2008 Apr 30;49(2):175-88. doi: 10.3349/ymj.2008.49.2.175. Yonsei Med J. 2008. PMID: 18452252 Free PMC article. Review.
-
Memantine fails to facilitate partial cigarette deprivation in smokers--no role of Memantine in the treatment of nicotine dependency?J Neural Transm (Vienna). 2007 Mar;114(3):351-7. doi: 10.1007/s00702-006-0570-y. Epub 2006 Oct 18. J Neural Transm (Vienna). 2007. PMID: 17043926 Clinical Trial.
-
Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.Pharmacol Biochem Behav. 2024 Oct;243:173836. doi: 10.1016/j.pbb.2024.173836. Epub 2024 Jul 26. Pharmacol Biochem Behav. 2024. PMID: 39067531 Review.
-
Nicotine response genetics in the zebrafish.Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18662-7. doi: 10.1073/pnas.0908247106. Epub 2009 Oct 26. Proc Natl Acad Sci U S A. 2009. PMID: 19858493 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources